Evaluating a Tobacco Harm Reduction Strategy Among Clients Enrolled in Substance Use Disorder Treatment

Sponsor:

NIH/NIDA

Sponsor Study ID:

R01DA059969

CTO #:

104065

NCT Number:

NCT06922617

Phase:

N/A

Protocol Type:

Prevention

Age Group:

Adults

Disease Sites:

Study Objectives:

Evaluate if switching to ENDS leads to greater rates of 7-day biologically confirmed point prevalence abstinence (PPA) from cigarette smoking at 12 weeks compared to quitting with NRT among those enrolled in SUD treatment. Evaluate patient, provider, and organizational-level implementation outcomes using mixed methods according to the Proctor framework. Outcomes include: acceptability, appropriateness and feasibility. Quantitative data will be supplemented with in-depth interviews with patients (n=25), providers (n=10), and organizational stakeholders (n=6) to identify barriers and facilitators to implementation

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)